# SwissHealth Ventures

> SwissHealth Ventures is a VC fund backing Health Care, Medical and Software. See 10 investments, round sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 10
- Last investment: Feb 2026
- Lead investor: 50%
- Last updated: Aug 2026

SwissHealth Ventures is a VC fund focused on Health Care and Medical. SwissHealth Ventures AG forms its own company, whose investment activities are planned and controlled by the insurance group with Redstone. The company’s investment focus is on advancing concepts in the areas of prevention, recovery, care and special treatment, and on further developing and expanding innovative start-ups with a focus ontelemedicine, early detection diagnostics and digital tools for the chronically ill. SwissHealth Ventures positions itself with relevant expertise in the areas of healthcare and venture capital investment as a professional investor for ambitious start-ups and thus sets the course for the high-quality, cost-efficient healthcare of the future.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 9 | 90% |
| Medical | 3 | 30% |
| Software | 3 | 30% |
| Medical Device | 3 | 30% |
| mHealth | 2 | 20% |

21 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 6 | 60% |
| Seed | 3 | 30% |
| Series B | 1 | 10% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Germany | 6 | 60% |
| Switzerland | 2 | 20% |
| Sweden | 1 | 10% |
| Denmark | 1 | 10% |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Oska Health | Oska Health delivers digital-enabled care solutions for chronic kidney disease patients, a top clinical need for healthcare payers. By leveraging evidence-based medical best practices and behavioral science, Oska Health aims to empower individuals with kidney disease to mitigate their risk of cardiovascular complications and kidney failure whilesimultaneously lowering costs of care. The company partners with healthcare payers to provide a comprehensive solution that includes a personal coach, a state-of-the-art health app, and intelligent treatment plan algorithms, all designed to help individuals establish new routines and achieve optimal health outcomes. | $13M | Seed | Feb 26, 2026 |  |
| Hemi Health | Hemi Health is a Danish digital-first headache and migraine clinic specializing in diagnosis, personalized treatment, and care for headaches using technology like an app for symptom tracking and video consultations. | $4.7M | Seed | Feb 20, 2026 |  |
| deepc | Our vision: We strive to enable immediate access to precise and safe diagnostics for every person in the world. Building the Diagnostics OS - a cutting-edge web-based AI software framework, enabling medical professionals and AI companies to seamlessly integrate medical diagnostic AI and other digital products into the clinical workflow, such asin radiology - screening medical data in real-time, enhancing the diagnostic quality, and improving cost-efficiency.deepc was awarded the main prize by the Federal Ministry for Economic Affairs and Energy (BMWi) with both the Founder's Prize and the Special Prize in the field of healthcare | $13M | Series A | Jul 25, 2024 |  |
| Kranus Health | Kranus Health is a global provider for Men‘s Health Prescription Digital Therapeutics (PDTs). Our therapies make millions of men live a better and longer life and enable doctors to treat their patients more efficiently. | $8.5M | Series A | Oct 02, 2023 |  |
| marta | German Version below:marta offers a market place for families, people in need of care and European caregivers. We believe that, on the one hand everyone has the right to receive appropriate care and to age with dignity and on the other hand caregivers should be able to do their work under fair conditions.We are working on software solutions toconnect caregivers with families across Europe and we support both parties during the entire process. In our own families we have seen that the current market is characterized by non-transparent services and does not deliver adequate quality. It is out mission to change that.That is why we at marta pursue the goal of making things better by applying our software solutions to fundamentally rebuilding the "24-hour" care market.Deutsche Version:marta bietet einen Marketplatz für Familien, pflegebedürftige Menschen und europäische Pflegekräfte. Aus unserer Sicht, hat zum einen jede/r das Recht darauf, angemessene Pflege zu erhalten und in Würde zu altern und zum anderen sollten Pflegekräfte unter fairen Bedingungen ihre Arbeit machen können.Wir arbeiten an dem Bau von Softwarelösungen, um Pflegekräfte mit Familien in ganz Europa zu verbinden und während der Betreuung zu begleiten. In unseren eigenen Familien haben wir gesehen, dass der derzeitige Markt von intransparenten Dienstleistungen geprägt ist und keine angemessene Qualität liefert.Deswegen verfolgen wir bei marta das Ziel, es durch unsere Softwarelösungen besser zu machen und den Markt der "24-Stunden" Pflege grundlegend neu aufzubauen. |  | Seed | Aug 03, 2023 |  |
| heartbeat medical | Heartbeat enables providers to learn from the most important data point in healthcare: quality of life. We are experts in the field of Patient Reported Outcome Measures (PROMs) and passionate about generating high-quality Real World Evidence. | $12.7M | Series A | Apr 28, 2022 |  |
| Humanoo | HUMANOO \| MAKING PEOPLE HEALTHIER! HUMANOO is the digital health platform for employees and insurance clients. We enable our users to improve their physical and mental health. Simple, effective, proven - all in one app. With customized programs and innovative eHealth solutions, we guide our users in the areas of fitness, physio, yoga, mindfulnessand nutrition to their self-imposed goals. For the first time, companies and insurance companies can use comprehensive decentralized analysis to understand the health of their employees or insurance clients and make it a measurable success. Our team currently consists of 65 employees from 15 nations with different talents. In our office in Berlin-Kreuzberg, software developers, designers, marketing and sales specialists work together with sports and nutrition scientists as well as yoga teachers and physiotherapists. What we share is the goal to motivate people to stay healthy. | $10M | Series B | Aug 13, 2021 |  |
| Flow Neuroscience | Flow Neuroscience is a healthcare company that develops depression treatment devices that combines an easy-to-use brain stimulation headset with a personalized mobile app to target both the physical and behavioral elements of Major Depressive Disorder (MDD). The company's wearable stimulates a patient's left frontal lobe, the area of thebrain that has often lowered activity in people suffering from depression.Flow Neuroscience combines their wearable with a mobile app that nudges users to behaviors that will help lessen the effects of their depression, including exercise and regular sleeping patterns.The company's hope is to make available for the public a treatment that's currently only used in clinics specialized in brain stimulation. It also wants to make the treatment affordable enough to seriously challenge a dominant pharmaceuticals industry. | $10M | Series A | Aug 10, 2021 |  |
| OnlineDoctor | OnlineDoctor is an innovative Swiss-based platform that allows the user to diagnosed any skin problems quickly (within 48h), location-independent and cost-effectively by an independent dermatologist. OnlineDoctor is suitable for the evaluation of all kinds of skin problems such as rash, eczema, birthmark and many more. The company'suncomplicated, high-quality platform provides a service that benefits all parties. | $6.2M | Series A | Dec 18, 2020 |  |
| Pregnolia | Pregnolia ensures that every woman can have a happy, healthy and informed pregnancy until term. Their team knows that the existing research about preterm birth assessment is very promising, but this alone does not guarantee success. Sabrina, Francisco and Annette are highly committed to develop the commercial version of the device, complete theclinical trial, follow the regulatory roadmap and execute on their business vision to successfully support gynaecologists in improving the preterm birth risk assessment and birth management. | $4.4M | Series A | Jun 25, 2020 |  |

10 of 10 investments shown.

## Co-investors
- [Redstone.VC](https://shizune.co/investors/profile/redstone-digital-gmbh) — VC Fund, 6 deals together
- [Verve Ventures](https://shizune.co/investors/profile/verve-ventures) — VC Fund, 2 deals together
- [Alliance VC](https://shizune.co/investors/profile/alliance-venture) — VC Fund, 1 deal together
- [A Round Capital](https://shizune.co/investors/profile/a-round-capital-d06f) — VC Fund, 1 deal together
- [Aurum Impact](https://shizune.co/investors/profile/aurum-impact) — VC Fund, 1 deal together
- [Bertelsmann Investments](https://shizune.co/investors/profile/bertelsmann-investments) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Innova Memphis](https://shizune.co/investors/profile/innova-memphis) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Enterprise Ireland](https://shizune.co/investors/profile/enterprise-ireland) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund
- [HV Capital](https://shizune.co/investors/profile/holtzbrinck-ventures) — VC Fund
- [IBB Ventures](https://shizune.co/investors/profile/ibb) — VC Fund

## Featured in investor lists
- [Medical Investors in Germany](https://shizune.co/investors/medical-investors-germany)
- [Medical Device Investors in Germany](https://shizune.co/investors/medical-device-investors-germany)
- [Medical Device VC Funds in Germany](https://shizune.co/investors/medical-device-vc-funds-germany)

## FAQ

### What does SwissHealth Ventures invest in?

SwissHealth Ventures invests primarily in Health Care, Medical and Software startups, most often at Series A and Seed stage. Most of the 10 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did SwissHealth Ventures last invest?

The most recent investment recorded for SwissHealth Ventures closed in Feb 2026. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co